Form 8-K - Current report:
SEC Accession No. 0001437749-25-016447
Filing Date
2025-05-13
Accepted
2025-05-13 16:09:52
Documents
17
Period of Report
2025-05-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20250123_8k.htm   iXBRL 8-K 29983
2 EXHIBIT 99.1 ex_817334.htm EX-99.1 28980
7 ex_817334img001.jpg GRAPHIC 76841
8 ex_817334img002.jpg GRAPHIC 38816
  Complete submission text file 0001437749-25-016447.txt   364634

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20250513.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20250513_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20250513_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20250513_pre.xml EX-101.PRE 11584
19 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20250123_8k_htm.xml XML 2873
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 25940144
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)